Adenocarcinoma of prostate
Item
histologically confirmed diagnosis of adenocarcinoma of the prostate
boolean
C0007112 (UMLS CUI [1])
Biopsy of prostate | Evaluation Histologic | Gleason score
Item
histological evaluation of prostate biopsy with assignment of a gleason score to the biopsy material; gleason scores ≤ 7
boolean
C0194804 (UMLS CUI [1])
C0220825 (UMLS CUI [2,1])
C0205462 (UMLS CUI [2,2])
C3203027 (UMLS CUI [3])
TNM clinical staging
Item
clinical stage t1-2b (ajcc 7th edition)
boolean
C3258246 (UMLS CUI [1])
Prostate specific antigen measurement | Biopsy of prostate
Item
psa ≤ 10 ng/ml. psa should not be obtained within 10 days after prostate biopsy.
boolean
C0201544 (UMLS CUI [1])
C0194804 (UMLS CUI [2])
ECOG performance status
Item
ecog performance status 0-1
boolean
C1520224 (UMLS CUI [1])
invasive cancer | Skin carcinoma | Lymphoma | Malignant Neoplasms hematogenous
Item
prior or concurrent invasive malignancy (except non-melanomatous skin cancer) or lymphomatous/hematogenous malignancy unless continually disease free for a minimum of 5 years.
boolean
C0677898 (UMLS CUI [1])
C0699893 (UMLS CUI [2])
C0024299 (UMLS CUI [3])
C0006826 (UMLS CUI [4,1])
C1512376 (UMLS CUI [4,2])
distant metastases
Item
evidence of distant metastases
boolean
C3258247 (UMLS CUI [1])
Lymph Node Involvement regional
Item
regional lymph node involvement
boolean
C0806692 (UMLS CUI [1,1])
C0205147 (UMLS CUI [1,2])
H/O: surgery Radical | Prostatectomy | Cryosurgery | High intensity focused ultrasound Prostate carcinoma | Pelvis Therapeutic radiology procedure Previous | Brachytherapy to prostate | Male Castration
Item
previous radical surgery (prostatectomy), cryosurgery, or hifu for prostate cancer. previous pelvic irradiation, prostate brachytherapy, or bilateral orchiectomy
boolean
C0455610 (UMLS CUI [1,1])
C0439807 (UMLS CUI [1,2])
C0033573 (UMLS CUI [2])
C0010408 (UMLS CUI [3])
C0441583 (UMLS CUI [4,1])
C0600139 (UMLS CUI [4,2])
C0030797 (UMLS CUI [5,1])
C1522449 (UMLS CUI [5,2])
C0205156 (UMLS CUI [5,3])
C0854662 (UMLS CUI [6])
C0007347 (UMLS CUI [7])
Prior Hormone Therapy | LHRH Agonist | LHRH antagonist | Androgen Antagonists | Estrogens | Castration
Item
previous hormonal therapy, such as lhrh agonists or lhrh antagonists, anti-androgens, estrogens, or surgical castration
boolean
C1514460 (UMLS CUI [1])
C1518041 (UMLS CUI [2])
C1276926 (UMLS CUI [3])
C0002842 (UMLS CUI [4])
C0014939 (UMLS CUI [5])
C0007344 (UMLS CUI [6])
Finasteride Use | Dutasteride Use | Prostate-Specific Antigen
Item
use of finasteride or dutasteride within 30 days prior to registration. psa should not be obtained prior to 30 days after stopping finasteride or dutasteride.
boolean
C0060389 (UMLS CUI [1,1])
C1524063 (UMLS CUI [1,2])
C0754659 (UMLS CUI [2,1])
C1524063 (UMLS CUI [2,2])
C0138741 (UMLS CUI [3])
Cytotoxic Chemotherapy Prostate carcinoma
Item
previous or concurrent cytotoxic chemotherapy for prostate cancer
boolean
C0677881 (UMLS CUI [1,1])
C0600139 (UMLS CUI [1,2])
Age
Item
age < 18
boolean
C0001779 (UMLS CUI [1])
Informed Consent Unable
Item
patient unable to provide study-specific informed consent
boolean
C0021430 (UMLS CUI [1,1])
C1299582 (UMLS CUI [1,2])
Expanded Prostate Cancer Index Composite Questionnaire | Completion Unable
Item
inability to complete the expanded prostate cancer index composite (epic) questionnaire
boolean
C3810535 (UMLS CUI [1,1])
C0034394 (UMLS CUI [1,2])
C0205197 (UMLS CUI [2,1])
C1299582 (UMLS CUI [2,2])